Danhong Injection in the Treatment of Acute Ischemic Stroke

This study is currently recruiting participants.

See

Contacts and Locations

Verified October 2016 by Zhong Wang, China Academy of Chinese Medical Sciences

Sponsor:

ClinicalTrials.gov Identifier:

NCT01677208

First Posted: August 31, 2012

Last Update Posted: October 11, 2016

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Collaborator:

China Food and Drug Administration

Information provided by (Responsible Party):

Zhong Wang, China Academy of Chinese Medical Sciences

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2019 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Li B, Wang Y, Lu J, Liu J, Yuan Y, Yu Y, Wang P, Zhao X, Wang Z. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial. Trials. 2015 Dec 9;16:561. doi: 10.1186/s13063-015-1076-4.

To Top